Balance Sheet Accounts (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventory, Net

Inventory, Net



						March 31, 2025						December 31, 2024
						(in thousands)
Raw materials						$	48,126					$	41,310
Work in process						2,453						2,454
Finished goods						39,846						35,002
Total inventory, net						$	90,425					$	78,766

Schedule of Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets




						March 31, 2025						December 31, 2024
						(in thousands)
Prepaid insurance						$	2,008					$	2,768

Prepaid services						1,045						571
Prepaid taxes						380						458
Prepaid assets						492						505
Prepaid raw materials and accessories						802						1,005
Prepaid U.S. clinical trial costs						139						184
Prepaid warranty and distribution rights						407						409
Prepaid software						1,052						408
Other						2,532						2,614
Total prepaid expenses						$	8,857					$	8,922

Schedule of Property and Equipment, Net

Property and Equipment, Net



						March 31, 2025						December 31, 2024
						(in thousands)
Machinery and equipment						$	22,500					$	22,764
Building improvements						17,041						16,902
Furniture and fixtures						14,885						14,772
Building						37,227						37,227
Leasehold improvements						2,561						2,516
Land						3,694						3,694
Vehicles						273						269
Construction in process						—						—
Total						98,181						98,144
Less: Accumulated depreciation and amortization						(21,791)						(20,116)
Total property and equipment, net						$	76,390					$	78,028

Schedule of Accrued Liabilities




						March 31, 2025						December 31, 2024
						(in thousands)
Performance bonus						$	8,001					$	6,235
Payroll and related expenses						6,282						4,832
Operating lease liabilities - current						1,558						1,514
Commissions						2,427						1,312
Professional and legal services						1,339						876
Taxes						177						153
Warranty reserve						153						141


Other						667						1,473
Total accrued liabilities						$	20,604					$	16,536

Schedule of Short-term Debt




						March 31, 2025						December 31, 2024
						(in thousands)

Deferred revenue						$	1,444					$	1,749
Consideration payable for business acquisitions						851						2,774
Contingent consideration payable for business acquisitions						—						737
Other						951						1,722

Total other liabilities, short-term						$	3,246					$	6,982

Schedule of Long-term Debt




						March 31, 2025						December 31, 2024
						(in thousands)
Deferred revenue						$	1,080					$	1,124

Consideration payable for business acquisitions						290						278
Contingent consideration payable for business acquisitions						182						174
Other						81						102
Total other liabilities, long-term						$	1,633					$	1,678